| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA6 ARID1B SMARCC2 MAML2 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP EP300 MED13 | 1.42e-11 | 303 | 65 | 13 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NCOA6 ARID1B SMARCC2 MAML2 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP SF1 EP300 MED13 | 2.72e-09 | 562 | 65 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin binding | FLI1 NCOA6 ARID1B PBRM1 EP400 GLI1 GLI2 SMARCC2 DLX1 PAX6 ARID1A CREBBP EP300 | 6.11e-07 | 739 | 65 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA6 ARID1B HGS SMARCC2 MAML2 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP CAPRIN1 SF1 EP300 MED13 | 6.60e-07 | 1160 | 65 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA6 ARID1B HGS SMARCC2 MAML2 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP CAPRIN1 SF1 EP300 MED13 TAB3 | 1.03e-06 | 1356 | 65 | 17 | GO:0060090 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.04e-05 | 2 | 65 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.04e-05 | 2 | 65 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.12e-05 | 3 | 65 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.20e-05 | 21 | 65 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 4.64e-05 | 61 | 65 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 1.55e-04 | 6 | 65 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.78e-04 | 86 | 65 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.12e-04 | 167 | 65 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 6.33e-04 | 120 | 65 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 6.74e-04 | 12 | 65 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 7.25e-04 | 54 | 65 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 9.26e-04 | 14 | 65 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.07e-03 | 15 | 65 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.13e-03 | 140 | 65 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.22e-03 | 16 | 65 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 1.54e-03 | 18 | 65 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.91e-03 | 20 | 65 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.10e-03 | 1244 | 65 | 11 | GO:0000978 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.10e-03 | 78 | 65 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.34e-03 | 417 | 65 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ATF7 FLI1 ZNF536 GLI1 GLI2 ZFHX3 DLX1 PAX6 CREBBP EP300 CREB5 TBP | 2.38e-03 | 1459 | 65 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.48e-03 | 1271 | 65 | 11 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.98e-03 | 753 | 65 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 2.98e-03 | 25 | 65 | 2 | GO:0000979 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.23e-03 | 187 | 65 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 3.47e-03 | 27 | 65 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | nucleosome binding | 4.02e-03 | 98 | 65 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.49e-03 | 102 | 65 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 4.74e-03 | 104 | 65 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 5.47e-03 | 34 | 65 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 5.79e-03 | 35 | 65 | 2 | GO:0051019 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 6.46e-03 | 37 | 65 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 6.46e-03 | 37 | 65 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | zinc ion binding | 8.10e-03 | 891 | 65 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | tau protein binding | 9.85e-03 | 46 | 65 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.15e-02 | 582 | 65 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.20e-02 | 51 | 65 | 2 | GO:0004402 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ATF7 FLI1 BCL9L NCOA6 GLI1 GLI2 ZFHX3 DLX1 MAML2 PAX6 ZMIZ1 SSBP4 BCL9 SSBP3 SS18 CREBBP EP300 MED13 CREB5 TBP | 3.65e-09 | 1390 | 64 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 2.11e-07 | 136 | 64 | 7 | GO:0045445 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 3.11e-07 | 144 | 64 | 7 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 4.92e-07 | 95 | 64 | 6 | GO:2000781 | |
| GeneOntologyBiologicalProcess | head development | NCOA6 C2CD3 ATXN2 GLI1 GLI2 SEC16A DAB1 DLX1 PAX6 ZMIZ1 SSBP3 ARID1A CREBBP EP300 | 6.58e-07 | 919 | 64 | 14 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 6.90e-07 | 54 | 64 | 5 | GO:0045663 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 6.91e-07 | 162 | 64 | 7 | GO:0045621 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 8.44e-07 | 333 | 64 | 9 | GO:0051054 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BCL9L FNDC3B ARID1B PBRM1 GLI2 DAB1 SMARCC2 ZFHX3 DLX1 PAX6 ZMIZ1 ARID1A CAPRIN1 PICALM EP300 | 1.56e-06 | 1141 | 64 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.89e-06 | 29 | 64 | 4 | GO:2000819 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 5.38e-06 | 143 | 64 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 6.07e-06 | 146 | 64 | 6 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 6.32e-06 | 226 | 64 | 7 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 8.63e-06 | 42 | 64 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | notochord regression | 9.48e-06 | 2 | 64 | 2 | GO:0060032 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 9.80e-06 | 92 | 64 | 5 | GO:0045661 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 9.87e-06 | 242 | 64 | 7 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 9.87e-06 | 242 | 64 | 7 | GO:1903708 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.04e-05 | 44 | 64 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | brain development | NCOA6 C2CD3 ATXN2 GLI1 GLI2 SEC16A DAB1 DLX1 PAX6 ZMIZ1 SSBP3 ARID1A | 1.12e-05 | 859 | 64 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | ARID1B PBRM1 GLI2 SMARCC2 PAX6 ZMIZ1 ARID1A CAPRIN1 PICALM EP300 | 1.81e-05 | 614 | 64 | 10 | GO:0010720 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.82e-05 | 266 | 64 | 7 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 3.16e-05 | 290 | 64 | 7 | GO:0050870 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 3.61e-05 | 60 | 64 | 4 | GO:0021587 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 4.45e-05 | 306 | 64 | 7 | GO:0044843 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 4.66e-05 | 64 | 64 | 4 | GO:0021575 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 5.56e-05 | 317 | 64 | 7 | GO:1903039 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 5.66e-05 | 4 | 64 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 5.79e-05 | 564 | 64 | 9 | GO:0051052 | |
| GeneOntologyBiologicalProcess | cerebellum development | 7.16e-05 | 139 | 64 | 5 | GO:0021549 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 8.06e-05 | 231 | 64 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 8.65e-05 | 234 | 64 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 9.11e-05 | 343 | 64 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | ATF7 NCOA6 C2CD3 PBRM1 GLI2 DLX1 PAX6 ZMIZ1 SSBP3 ARID1A EP300 | 9.73e-05 | 906 | 64 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | heart development | 1.05e-04 | 757 | 64 | 10 | GO:0007507 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.13e-04 | 153 | 64 | 5 | GO:0022037 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.14e-04 | 246 | 64 | 6 | GO:1902806 | |
| GeneOntologyBiologicalProcess | regulation of cell development | ARID1B PBRM1 GLI2 DAB1 SMARCC2 DLX1 PAX6 ZMIZ1 ARID1A CAPRIN1 PICALM EP300 | 1.20e-04 | 1095 | 64 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ATF7 NCOA6 C2CD3 PBRM1 GLI2 DLX1 PAX6 ZMIZ1 SSBP3 ARID1A EP300 | 1.21e-04 | 929 | 64 | 11 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 1.39e-04 | 255 | 64 | 6 | GO:0045664 | |
| GeneOntologyBiologicalProcess | radial glia-guided pyramidal neuron migration | 1.41e-04 | 6 | 64 | 2 | GO:0140650 | |
| GeneOntologyBiologicalProcess | ventral midline development | 1.41e-04 | 6 | 64 | 2 | GO:0007418 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 1.62e-04 | 88 | 64 | 4 | GO:0006289 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.77e-04 | 382 | 64 | 7 | GO:0030217 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.86e-04 | 385 | 64 | 7 | GO:0051251 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 1.93e-04 | 271 | 64 | 6 | GO:0000082 | |
| GeneOntologyBiologicalProcess | formation of anatomical boundary | 1.97e-04 | 7 | 64 | 2 | GO:0048859 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.98e-04 | 389 | 64 | 7 | GO:0022409 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 2.05e-04 | 37 | 64 | 3 | GO:0009954 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 2.17e-04 | 176 | 64 | 5 | GO:0007224 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 2.17e-04 | 95 | 64 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 2.45e-04 | 98 | 64 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 2.64e-04 | 100 | 64 | 4 | GO:0007091 | |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 C2CD3 ATXN2 GLI1 GLI2 SEC16A DAB1 DLX1 PAX6 ZMIZ1 SSBP3 ARID1A | 2.74e-04 | 1197 | 64 | 12 | GO:0007417 |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 2.80e-04 | 186 | 64 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 2.96e-04 | 103 | 64 | 4 | GO:0044784 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ATF7 ZNF536 MAGEL2 GLI2 SMARCC2 ZFHX3 DLX1 PAX6 ARID1A PSPC1 CREBBP SF1 EP300 | 3.08e-04 | 1399 | 64 | 13 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 3.19e-04 | 105 | 64 | 4 | GO:0008589 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 3.29e-04 | 423 | 64 | 7 | GO:0002696 | |
| GeneOntologyBiologicalProcess | hemopoiesis | ATF7 FLI1 NCOA6 ARID1B PBRM1 GLI2 SMARCC2 ZMIZ1 SSBP3 ARID1A PICALM EP300 | 3.33e-04 | 1223 | 64 | 12 | GO:0030097 |
| GeneOntologyBiologicalProcess | neural plate pattern specification | 3.36e-04 | 9 | 64 | 2 | GO:0060896 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ATF7 ZNF536 MAGEL2 GLI2 SMARCC2 ZFHX3 DLX1 PAX6 ARID1A PSPC1 CREBBP SF1 EP300 | 3.39e-04 | 1413 | 64 | 13 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 3.48e-04 | 195 | 64 | 5 | GO:1903844 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 3.59e-04 | 429 | 64 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ATF7 ZNF536 MAGEL2 GLI2 SMARCC2 ZFHX3 DLX1 PAX6 ARID1A CREBBP EP300 | 3.59e-04 | 1053 | 64 | 11 | GO:0000122 |
| GeneOntologyBiologicalProcess | response to growth factor | 3.65e-04 | 883 | 64 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | pituitary gland development | 3.68e-04 | 45 | 64 | 3 | GO:0021983 | |
| GeneOntologyBiologicalProcess | neural tube patterning | 3.68e-04 | 45 | 64 | 3 | GO:0021532 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 3.93e-04 | 46 | 64 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 3.94e-04 | 111 | 64 | 4 | GO:0033045 | |
| GeneOntologyBiologicalProcess | embryo development | ATF7 NCOA6 C2CD3 PBRM1 GLI1 GLI2 DLX1 PAX6 ZMIZ1 SSBP3 ARID1A CREBBP EP300 | 3.99e-04 | 1437 | 64 | 13 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 4.08e-04 | 579 | 64 | 8 | GO:0045785 | |
| GeneOntologyBiologicalProcess | neural tube development | 4.09e-04 | 202 | 64 | 5 | GO:0021915 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 4.46e-04 | 741 | 64 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 4.46e-04 | 48 | 64 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 4.46e-04 | 48 | 64 | 3 | GO:0021696 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.47e-04 | 445 | 64 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 4.59e-04 | 447 | 64 | 7 | GO:1903037 | |
| GeneOntologyBiologicalProcess | hindbrain development | 4.68e-04 | 208 | 64 | 5 | GO:0030902 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 4.71e-04 | 449 | 64 | 7 | GO:0050867 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 5.00e-04 | 324 | 64 | 6 | GO:0006302 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 5.21e-04 | 213 | 64 | 5 | GO:2000045 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 5.30e-04 | 458 | 64 | 7 | GO:0050863 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 5.34e-04 | 51 | 64 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 5.67e-04 | 217 | 64 | 5 | GO:0021953 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 5.80e-04 | 123 | 64 | 4 | GO:0045666 | |
| GeneOntologyBiologicalProcess | dendrite development | 5.96e-04 | 335 | 64 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | forebrain neuron differentiation | 5.97e-04 | 53 | 64 | 3 | GO:0021879 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 6.05e-04 | 336 | 64 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | notochord morphogenesis | 6.13e-04 | 12 | 64 | 2 | GO:0048570 | |
| GeneOntologyBiologicalProcess | regionalization | 6.83e-04 | 478 | 64 | 7 | GO:0003002 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 7.16e-04 | 347 | 64 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.17e-04 | 482 | 64 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 7.40e-04 | 57 | 64 | 3 | GO:0021517 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 7.52e-04 | 486 | 64 | 7 | GO:0007159 | |
| GeneOntologyBiologicalProcess | forebrain development | 7.80e-04 | 489 | 64 | 7 | GO:0030900 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 8.43e-04 | 237 | 64 | 5 | GO:0019827 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 9.17e-04 | 139 | 64 | 4 | GO:0051983 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 9.26e-04 | 242 | 64 | 5 | GO:0098727 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ARID1B PBRM1 EP400 SMARCC2 PAX6 ARID1A SS18 CREBBP EP300 TBP | 9.51e-04 | 999 | 64 | 10 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ATF7 BCL9L NCOA6 ARID1B PBRM1 EP400 WDR33 CSTF2 SMARCC2 BCL9 ARID1A SNRPA SS18 CREBBP PRPF40A SF1 MED13 MX2 TBP | 8.90e-09 | 1377 | 62 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.62e-08 | 30 | 62 | 5 | GO:0016514 | |
| GeneOntologyCellularComponent | npBAF complex | 6.87e-08 | 14 | 62 | 4 | GO:0071564 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.00e-07 | 96 | 62 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | chromatin | ATF7 FLI1 ARID1B PBRM1 EP400 ADNP2 SMARCC2 ZFHX3 DLX1 PAX6 ZMIZ1 ARID1A SS18 CREBBP EP300 CREB5 TBP | 8.93e-07 | 1480 | 62 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | ATPase complex | 2.28e-06 | 129 | 62 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | bBAF complex | 2.94e-06 | 10 | 62 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | brahma complex | 8.84e-06 | 14 | 62 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | transcription regulator complex | 9.32e-06 | 596 | 62 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | nBAF complex | 1.35e-05 | 16 | 62 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 5.17e-05 | 4 | 62 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | nuclear body | FLI1 EP400 PABPN1 GLI2 CSTF2 ZFHX3 MAML2 PSPC1 CREBBP PRPF40A SF1 | 6.20e-05 | 903 | 62 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 1.52e-04 | 35 | 62 | 3 | GO:0099243 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.63e-04 | 42 | 62 | 3 | GO:0070971 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 5.60e-04 | 12 | 62 | 2 | GO:0098892 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 6.61e-04 | 13 | 62 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | nuclear matrix | 7.96e-04 | 140 | 62 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | RSC-type complex | 8.86e-04 | 15 | 62 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.27e-03 | 272 | 62 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 1.28e-03 | 18 | 62 | 2 | GO:0098888 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.67e-03 | 171 | 62 | 4 | GO:0034399 | |
| GeneOntologyCellularComponent | nuclear speck | 1.72e-03 | 431 | 62 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 1.92e-03 | 22 | 62 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 2.69e-03 | 26 | 62 | 2 | GO:0005847 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.75e-03 | 94 | 62 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 3.66e-03 | 104 | 62 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 3.81e-03 | 31 | 62 | 2 | GO:0005849 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 4.17e-03 | 109 | 62 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 4.28e-03 | 110 | 62 | 3 | GO:0030134 | |
| GeneOntologyCellularComponent | U1 snRNP | 4.31e-03 | 33 | 62 | 2 | GO:0005685 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.33e-07 | 3 | 27 | 3 | HP:0005895 | |
| HumanPheno | Sporadic | 7.17e-07 | 103 | 27 | 7 | HP:0003745 | |
| HumanPheno | Plantar crease between first and second toes | 2.71e-05 | 2 | 27 | 2 | HP:0008107 | |
| HumanPheno | Cerebellar Purkinje layer atrophy | 2.71e-05 | 2 | 27 | 2 | HP:0012082 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.71e-05 | 2 | 27 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.71e-05 | 2 | 27 | 2 | HP:0001042 | |
| HumanPheno | Feeding difficulties | FLI1 ARID1B C2CD3 MAGEL2 ATXN2 PABPN1 GLI2 DAB1 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 TBP | 2.87e-05 | 982 | 27 | 15 | HP:0002022 |
| HumanPheno | Duplication of phalanx of hallux | 4.65e-05 | 14 | 27 | 3 | HP:0010066 | |
| HumanPheno | Hypoplastic fifth fingernail | 4.65e-05 | 14 | 27 | 3 | HP:0008398 | |
| HumanPheno | Unsteady gait | 5.57e-05 | 357 | 27 | 9 | HP:0002317 | |
| HumanPheno | Duplication of phalanx of toe | 5.79e-05 | 15 | 27 | 3 | HP:0010181 | |
| HumanPheno | Hyperactivity | FLI1 ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 | 6.23e-05 | 558 | 27 | 11 | HP:0000752 |
| HumanPheno | Abnormality of upper lip vermillion | ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 | 7.25e-05 | 464 | 27 | 10 | HP:0011339 |
| HumanPheno | Laryngeal cartilage malformation | 8.09e-05 | 3 | 27 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 8.09e-05 | 3 | 27 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 8.09e-05 | 3 | 27 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 8.09e-05 | 3 | 27 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 8.09e-05 | 3 | 27 | 2 | HP:0005322 | |
| HumanPheno | Prominent eyelashes | 8.60e-05 | 17 | 27 | 3 | HP:0011231 | |
| HumanPheno | Oral aversion | 8.60e-05 | 17 | 27 | 3 | HP:0012523 | |
| HumanPheno | Abnormal hallux phalanx morphology | 8.78e-05 | 46 | 27 | 4 | HP:0010057 | |
| HumanPheno | Prominent fingertip pads | 8.78e-05 | 46 | 27 | 4 | HP:0001212 | |
| HumanPheno | Heterotopias/abnormal migration | FLI1 ARID1B C2CD3 MAGEL2 ATXN2 GLI2 SMARCC2 PAX6 ZMIZ1 ARID1A | 9.18e-05 | 477 | 27 | 10 | HP:0007317 |
| HumanPheno | Abnormality of neuronal migration | FLI1 ARID1B C2CD3 MAGEL2 ATXN2 GLI2 SMARCC2 PAX6 ZMIZ1 ARID1A | 9.18e-05 | 477 | 27 | 10 | HP:0002269 |
| HumanPheno | Low anterior hairline | 9.35e-05 | 147 | 27 | 6 | HP:0000294 | |
| HumanPheno | Prominent digit pad | 1.04e-04 | 48 | 27 | 4 | HP:0011298 | |
| HumanPheno | Abnormal cortical gyration | 1.07e-04 | 388 | 27 | 9 | HP:0002536 | |
| HumanPheno | Thick eyebrow | 1.21e-04 | 154 | 27 | 6 | HP:0000574 | |
| HumanPheno | Hypoplastic fifth toenail | 1.22e-04 | 19 | 27 | 3 | HP:0011937 | |
| HumanPheno | Displacement of the urethral meatus | 1.28e-04 | 397 | 27 | 9 | HP:0100627 | |
| HumanPheno | Abnormal columella morphology | 1.31e-04 | 97 | 27 | 5 | HP:0009929 | |
| HumanPheno | Abnormal male urethral meatus morphology | 1.33e-04 | 399 | 27 | 9 | HP:0032076 | |
| HumanPheno | Narrow nasal bridge | 1.54e-04 | 53 | 27 | 4 | HP:0000446 | |
| HumanPheno | Trichiasis | 1.61e-04 | 4 | 27 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.61e-04 | 4 | 27 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.61e-04 | 4 | 27 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.61e-04 | 4 | 27 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.61e-04 | 4 | 27 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.61e-04 | 4 | 27 | 2 | HP:0031207 | |
| HumanPheno | Localized hirsutism | 1.66e-04 | 21 | 27 | 3 | HP:0009889 | |
| HumanPheno | Aggressive behavior | ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 TBP | 1.79e-04 | 516 | 27 | 10 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 TBP | 1.79e-04 | 516 | 27 | 10 | HP:0006919 |
| HumanPheno | Abnormally increased volition | FLI1 ARID1B MAGEL2 RBM12 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 TBP | 1.81e-04 | 869 | 27 | 13 | HP:5200263 |
| HumanPheno | Abnormality of dental eruption | 1.86e-04 | 240 | 27 | 7 | HP:0006292 | |
| HumanPheno | Low hanging columella | 1.91e-04 | 56 | 27 | 4 | HP:0009765 | |
| HumanPheno | Sleep apnea | 1.96e-04 | 168 | 27 | 6 | HP:0010535 | |
| HumanPheno | Sleep-related breathing disorders | 2.02e-04 | 169 | 27 | 6 | HP:5200283 | |
| HumanPheno | Thin vermilion border | ARID1B MAGEL2 GLI1 SMARCC2 ARID1A CREBBP CAPRIN1 EP300 MED13 | 2.49e-04 | 433 | 27 | 9 | HP:0000233 |
| HumanPheno | Broad hallux phalanx | 2.50e-04 | 24 | 27 | 3 | HP:0010059 | |
| HumanPheno | Papillary thyroid carcinoma | 2.50e-04 | 24 | 27 | 3 | HP:0002895 | |
| HumanPheno | Thin upper lip vermilion | 2.56e-04 | 339 | 27 | 8 | HP:0000219 | |
| HumanPheno | Thin lips | 2.56e-04 | 339 | 27 | 8 | HP:0000213 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.68e-04 | 5 | 27 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.68e-04 | 5 | 27 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.68e-04 | 5 | 27 | 2 | HP:0030421 | |
| HumanPheno | Cryptorchidism | FLI1 ARID1B C2CD3 MAGEL2 GLI1 GLI2 SMARCC2 PAX6 ZMIZ1 ARID1A CREBBP EP300 | 2.86e-04 | 780 | 27 | 12 | HP:0000028 |
| HumanPheno | Abnormal nasal septum morphology | 2.92e-04 | 115 | 27 | 5 | HP:0000419 | |
| HumanPheno | Deviation of toes | 3.29e-04 | 118 | 27 | 5 | HP:0100498 | |
| HumanPheno | Abnormal facial expression | 3.31e-04 | 185 | 27 | 6 | HP:0005346 | |
| HumanPheno | Disinhibition | FLI1 ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 TBP | 3.97e-04 | 807 | 27 | 12 | HP:0000734 |
| HumanPheno | Inappropriate behavior | FLI1 ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 TBP | 3.97e-04 | 807 | 27 | 12 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | FLI1 ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 TBP | 3.97e-04 | 807 | 27 | 12 | HP:5200123 |
| HumanPheno | Social disinhibition | FLI1 ARID1B MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 TBP | 3.97e-04 | 807 | 27 | 12 | HP:5200029 |
| HumanPheno | Hepatoblastoma | 3.98e-04 | 28 | 27 | 3 | HP:0002884 | |
| HumanPheno | Wide nasal base | 3.98e-04 | 28 | 27 | 3 | HP:0012810 | |
| HumanPheno | Large foramen magnum | 4.01e-04 | 6 | 27 | 2 | HP:0002700 | |
| HumanPheno | Coloboma | 4.22e-04 | 274 | 27 | 7 | HP:0000589 | |
| HumanPheno | Agenesis of corpus callosum | 4.26e-04 | 365 | 27 | 8 | HP:0001274 | |
| HumanPheno | Abnormality of the urethra | 4.27e-04 | 465 | 27 | 9 | HP:0000795 | |
| HumanPheno | Constipation | 4.77e-04 | 472 | 27 | 9 | HP:0002019 | |
| HumanPheno | Abnormal nasal base norphology | 4.90e-04 | 30 | 27 | 3 | HP:0012808 | |
| HumanPheno | Preaxial foot polydactyly | 4.90e-04 | 30 | 27 | 3 | HP:0001841 | |
| HumanPheno | Long eyelashes | 4.97e-04 | 129 | 27 | 5 | HP:0000527 | |
| HumanPheno | Neoplasm by anatomical site | MST1R FLI1 ARID1B C2CD3 PBRM1 GLI1 GLI2 SMARCC2 PAX6 ARID1A CREBBP PICALM EP300 | 5.01e-04 | 959 | 27 | 13 | HP:0011793 |
| HumanPheno | Abnormal toe phalanx morphology | 5.15e-04 | 130 | 27 | 5 | HP:0010161 | |
| HumanPheno | Hypospadias | 5.30e-04 | 377 | 27 | 8 | HP:0000047 | |
| HumanPheno | Deviated nasal septum | 5.59e-04 | 7 | 27 | 2 | HP:0004411 | |
| HumanPheno | Abnormal penis morphology | ARID1B C2CD3 MAGEL2 GLI1 GLI2 SMARCC2 PAX6 ZMIZ1 ARID1A CREBBP EP300 | 5.67e-04 | 712 | 27 | 11 | HP:0000036 |
| HumanPheno | Feeding difficulties in infancy | FLI1 ARID1B C2CD3 MAGEL2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP EP300 | 5.70e-04 | 594 | 27 | 10 | HP:0008872 |
| HumanPheno | Sleep abnormality | C2CD3 MAGEL2 ATXN2 PABPN1 GLI2 SMARCC2 CREBBP CAPRIN1 EP300 TBP | 5.86e-04 | 596 | 27 | 10 | HP:0002360 |
| HumanPheno | Broad hallux | 6.19e-04 | 76 | 27 | 4 | HP:0010055 | |
| HumanPheno | Frontal upsweep of hair | 6.52e-04 | 33 | 27 | 3 | HP:0002236 | |
| HumanPheno | Neoplasm | MST1R FLI1 ARID1B C2CD3 PBRM1 GLI1 GLI2 SMARCC2 PAX6 ARID1A CREBBP PICALM EP300 | 6.70e-04 | 987 | 27 | 13 | HP:0002664 |
| HumanPheno | Obstructive sleep apnea | 7.17e-04 | 79 | 27 | 4 | HP:0002870 | |
| HumanPheno | Neoplasm of the liver | 7.23e-04 | 140 | 27 | 5 | HP:0002896 | |
| HumanPheno | Dysplastic corpus callosum | 7.25e-04 | 395 | 27 | 8 | HP:0006989 | |
| HumanPheno | Abnormality of the frontal hairline | 7.40e-04 | 215 | 27 | 6 | HP:0000599 | |
| HumanPheno | Impairment in personality functioning | FLI1 ARID1B MAGEL2 RBM12 ATXN2 GLI2 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 TBP | 7.56e-04 | 1141 | 27 | 14 | HP:0031466 |
| HumanPheno | Abnormal midbrain morphology | 8.26e-04 | 82 | 27 | 4 | HP:0002418 | |
| HumanPheno | Hypoplastic toenails | 8.26e-04 | 82 | 27 | 4 | HP:0001800 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 8.44e-04 | 36 | 27 | 3 | HP:0009617 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 8.56e-04 | 221 | 27 | 6 | HP:0000932 | |
| HumanPheno | Diagnostic behavioral phenotype | FLI1 ARID1B MAGEL2 RBM12 SMARCC2 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 MED13 | 8.61e-04 | 747 | 27 | 11 | HP:0025783 |
| HumanPheno | Embryonal neoplasm | 8.64e-04 | 83 | 27 | 4 | HP:0002898 | |
| HumanPheno | Simplified gyral pattern | 9.04e-04 | 84 | 27 | 4 | HP:0009879 | |
| HumanPheno | Ptosis | FLI1 ARID1B PABPN1 GLI2 SMARCC2 PAX6 ZMIZ1 ARID1A CREBBP CAPRIN1 EP300 | 9.33e-04 | 754 | 27 | 11 | HP:0000508 |
| HumanPheno | Pilomatrixoma | 9.52e-04 | 9 | 27 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 9.52e-04 | 9 | 27 | 2 | HP:0002341 | |
| HumanPheno | Natal tooth | 9.90e-04 | 38 | 27 | 3 | HP:0000695 | |
| HumanPheno | Broad toe | 1.03e-03 | 87 | 27 | 4 | HP:0001837 | |
| MousePheno | abnormal prenatal growth/weight/body size | FLI1 BCL9L NCOA6 C2CD3 RBM12 GLI2 HGS SMARCC2 PAX6 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP CAPRIN1 PICALM EP300 TBP | 2.73e-06 | 1493 | 56 | 19 | MP:0004196 |
| MousePheno | abnormal embryo size | FLI1 BCL9L NCOA6 C2CD3 GLI2 HGS SMARCC2 PAX6 ZMIZ1 BCL9 SSBP3 ARID1A CREBBP PICALM EP300 | 3.42e-06 | 956 | 56 | 15 | MP:0001697 |
| MousePheno | abnormal prenatal body size | FLI1 BCL9L NCOA6 C2CD3 GLI2 HGS SMARCC2 PAX6 ZMIZ1 BCL9 SSBP3 ARID1A CREBBP CAPRIN1 PICALM EP300 | 4.78e-06 | 1116 | 56 | 16 | MP:0010866 |
| MousePheno | embryonic lethality during organogenesis | FLI1 BCL9L NCOA6 C2CD3 EP400 HGS NEK7 ZMIZ1 SSBP3 ARID1A CREBBP SF1 EP300 TBP | 6.35e-06 | 876 | 56 | 14 | MP:0006207 |
| MousePheno | abnormal embryonic growth/weight/body size | FLI1 BCL9L NCOA6 C2CD3 RBM12 GLI2 HGS SMARCC2 PAX6 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP PICALM EP300 | 7.27e-06 | 1295 | 56 | 17 | MP:0002088 |
| MousePheno | decreased embryo size | FLI1 BCL9L NCOA6 GLI2 HGS PAX6 ZMIZ1 SSBP3 ARID1A CREBBP PICALM EP300 | 9.02e-06 | 659 | 56 | 12 | MP:0001698 |
| MousePheno | pale yolk sac | 7.64e-05 | 110 | 56 | 5 | MP:0001722 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | FLI1 BCL9L NCOA6 C2CD3 EP400 HGS ZMIZ1 ARID1A CREBBP SF1 EP300 | 8.67e-05 | 700 | 56 | 11 | MP:0011098 |
| MousePheno | abnormal neural tube morphology | 1.04e-04 | 591 | 56 | 10 | MP:0002151 | |
| MousePheno | open neural tube | 2.76e-04 | 226 | 56 | 6 | MP:0000929 | |
| MousePheno | postnatal lethality, incomplete penetrance | 2.85e-04 | 669 | 56 | 10 | MP:0011086 | |
| MousePheno | abnormal nervous system development | NCOA6 ARID1B C2CD3 RBM12 EP400 GLI2 HGS DAB1 PAX6 SSBP3 ARID1A SS18 CREBBP EP300 | 3.32e-04 | 1257 | 56 | 14 | MP:0003861 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | FNDC3B NCOA6 ARID1B PBRM1 GLI2 DAB1 SMARCC2 PAX6 ARID1A CREBBP CAPRIN1 PICALM EP300 CREB5 | 3.66e-04 | 1269 | 56 | 14 | MP:0011111 |
| MousePheno | abnormal embryonic tissue morphology | C2CD3 RBM12 EP400 GLI2 HGS CSTF2 ZMIZ1 SSBP3 ARID1A SS18 CREBBP PICALM EP300 | 3.69e-04 | 1116 | 56 | 13 | MP:0002085 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | NCOA6 MAGEL2 GLI2 DAB1 NEK7 SMARCC2 ZFHX3 PAX6 SSBP3 CREBBP PICALM EP300 TBP | 3.95e-04 | 1124 | 56 | 13 | MP:0011112 |
| MousePheno | perinatal lethality | FNDC3B NCOA6 ARID1B MAGEL2 GLI2 NEK7 SMARCC2 PAX6 ARID1A CREBBP CAPRIN1 EP300 CREB5 | 4.16e-04 | 1130 | 56 | 13 | MP:0002081 |
| MousePheno | embryonic growth arrest | 4.38e-04 | 346 | 56 | 7 | MP:0001730 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.16e-05 | 2 | 64 | 2 | IPR024670 | |
| Domain | BAF250_C | 1.16e-05 | 2 | 64 | 2 | IPR033388 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.16e-05 | 2 | 64 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.16e-05 | 2 | 64 | 2 | PF08214 | |
| Domain | KIX | 1.16e-05 | 2 | 64 | 2 | PS50952 | |
| Domain | BCL9 | 1.16e-05 | 2 | 64 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 1.16e-05 | 2 | 64 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.16e-05 | 2 | 64 | 2 | IPR031162 | |
| Domain | DUF902 | 1.16e-05 | 2 | 64 | 2 | PF06001 | |
| Domain | - | 1.16e-05 | 2 | 64 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.16e-05 | 2 | 64 | 2 | IPR010303 | |
| Domain | - | 1.16e-05 | 2 | 64 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.16e-05 | 2 | 64 | 2 | PF09030 | |
| Domain | - | 1.16e-05 | 2 | 64 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.16e-05 | 2 | 64 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.16e-05 | 2 | 64 | 2 | PS50134 | |
| Domain | BAF250_C | 1.16e-05 | 2 | 64 | 2 | PF12031 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.16e-05 | 2 | 64 | 2 | IPR013178 | |
| Domain | BAF250/Osa | 1.16e-05 | 2 | 64 | 2 | IPR021906 | |
| Domain | KAT11 | 1.16e-05 | 2 | 64 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.16e-05 | 2 | 64 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.16e-05 | 2 | 64 | 2 | IPR003101 | |
| Domain | KIX | 1.16e-05 | 2 | 64 | 2 | PF02172 | |
| Domain | Bcl-9 | 1.16e-05 | 2 | 64 | 2 | IPR015668 | |
| Domain | CBP_P300_HAT | 1.16e-05 | 2 | 64 | 2 | PS51727 | |
| Domain | SSDP_DNA-bd | 3.46e-05 | 3 | 64 | 2 | IPR008116 | |
| Domain | TF_CRE-BP1-typ | 3.46e-05 | 3 | 64 | 2 | IPR016378 | |
| Domain | Bromodomain_CS | 9.43e-05 | 26 | 64 | 3 | IPR018359 | |
| Domain | RRM | 9.81e-05 | 217 | 64 | 6 | SM00360 | |
| Domain | RRM_dom | 1.26e-04 | 227 | 64 | 6 | IPR000504 | |
| Domain | RRM | 1.35e-04 | 230 | 64 | 6 | PS50102 | |
| Domain | Nuc_rcpt_coact | 1.72e-04 | 6 | 64 | 2 | IPR009110 | |
| Domain | - | 1.86e-04 | 244 | 64 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.51e-04 | 258 | 64 | 6 | IPR012677 | |
| Domain | BROMODOMAIN_1 | 2.74e-04 | 37 | 64 | 3 | PS00633 | |
| Domain | Bromodomain | 2.97e-04 | 38 | 64 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.73e-04 | 41 | 64 | 3 | PS50014 | |
| Domain | BROMO | 4.00e-04 | 42 | 64 | 3 | SM00297 | |
| Domain | Bromodomain | 4.00e-04 | 42 | 64 | 3 | IPR001487 | |
| Domain | - | 4.00e-04 | 42 | 64 | 3 | 1.20.920.10 | |
| Domain | RRM_1 | 7.30e-04 | 208 | 64 | 5 | PF00076 | |
| Domain | Homeodomain-like | 9.50e-04 | 332 | 64 | 6 | IPR009057 | |
| Domain | - | 1.18e-03 | 15 | 64 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.18e-03 | 15 | 64 | 2 | SM00501 | |
| Domain | ARID_dom | 1.18e-03 | 15 | 64 | 2 | IPR001606 | |
| Domain | ARID | 1.18e-03 | 15 | 64 | 2 | PS51011 | |
| Domain | ARID | 1.18e-03 | 15 | 64 | 2 | PF01388 | |
| Domain | ZZ | 1.71e-03 | 18 | 64 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.71e-03 | 18 | 64 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.71e-03 | 18 | 64 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.90e-03 | 19 | 64 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.90e-03 | 19 | 64 | 2 | SM00291 | |
| Domain | - | 3.56e-03 | 26 | 64 | 2 | 1.25.40.90 | |
| Domain | LisH | 4.13e-03 | 28 | 64 | 2 | SM00667 | |
| Domain | LisH | 4.13e-03 | 28 | 64 | 2 | IPR006594 | |
| Domain | LISH | 4.13e-03 | 28 | 64 | 2 | PS50896 | |
| Domain | ZnF_U1 | 4.42e-03 | 29 | 64 | 2 | SM00451 | |
| Domain | Znf_U1 | 4.42e-03 | 29 | 64 | 2 | IPR003604 | |
| Domain | ENTH_VHS | 4.42e-03 | 29 | 64 | 2 | IPR008942 | |
| Domain | bZIP_1 | 6.04e-03 | 34 | 64 | 2 | PF00170 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 7.25e-08 | 31 | 50 | 5 | M39522 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.83e-07 | 37 | 50 | 5 | M27797 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.41e-06 | 24 | 50 | 4 | M13404 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.12e-06 | 29 | 50 | 4 | M48076 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.00e-06 | 34 | 50 | 4 | MM15531 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 9.03e-06 | 12 | 50 | 3 | M22006 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.42e-05 | 42 | 50 | 4 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.42e-05 | 42 | 50 | 4 | M17541 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.49e-05 | 14 | 50 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.28e-05 | 16 | 50 | 3 | M27121 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.93e-05 | 254 | 50 | 7 | M27131 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.30e-05 | 18 | 50 | 3 | M26942 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.53e-05 | 272 | 50 | 7 | M29619 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 4.59e-05 | 20 | 50 | 3 | M497 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.59e-05 | 20 | 50 | 3 | M27881 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 4.59e-05 | 20 | 50 | 3 | MM15469 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 6.17e-05 | 22 | 50 | 3 | MM15924 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.17e-05 | 22 | 50 | 3 | MM1370 | |
| Pathway | PID_RB_1PATHWAY | 8.08e-05 | 65 | 50 | 4 | M279 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.14e-05 | 25 | 50 | 3 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.03e-04 | 26 | 50 | 3 | M2499 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.03e-04 | 26 | 50 | 3 | MM14793 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.20e-04 | 137 | 50 | 5 | M48232 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.22e-04 | 5 | 50 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.22e-04 | 5 | 50 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.22e-04 | 5 | 50 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.22e-04 | 5 | 50 | 2 | M48023 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.44e-04 | 29 | 50 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.44e-04 | 29 | 50 | 3 | MM15444 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.65e-04 | 78 | 50 | 4 | M27234 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.81e-04 | 237 | 50 | 6 | M27786 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.83e-04 | 6 | 50 | 2 | M22062 | |
| Pathway | PID_REG_GR_PATHWAY | 2.00e-04 | 82 | 50 | 4 | M115 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.19e-04 | 84 | 50 | 4 | M1008 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ARID1B PBRM1 PABPN1 WDR33 GLI2 CSTF2 SMARCC2 ZFHX3 MAML2 ARID1A CREBBP EP300 MED13 TBP | 2.33e-04 | 1387 | 50 | 14 | M734 |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.54e-04 | 35 | 50 | 3 | M47969 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.56e-04 | 7 | 50 | 2 | MM1573 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 2.56e-04 | 7 | 50 | 2 | M27501 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.98e-04 | 91 | 50 | 4 | M27101 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.41e-04 | 8 | 50 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.41e-04 | 8 | 50 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.41e-04 | 8 | 50 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.41e-04 | 8 | 50 | 2 | M46443 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.52e-04 | 95 | 50 | 4 | M48268 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 3.66e-04 | 96 | 50 | 4 | M27784 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 3.78e-04 | 40 | 50 | 3 | MM14936 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 3.81e-04 | 97 | 50 | 4 | M48262 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.19e-04 | 277 | 50 | 6 | MM15414 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.37e-04 | 9 | 50 | 2 | M47451 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.70e-04 | 283 | 50 | 6 | M13087 | |
| Pathway | BIOCARTA_CPSF_PATHWAY | 5.45e-04 | 10 | 50 | 2 | M22041 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 5.45e-04 | 10 | 50 | 2 | MM1532 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.45e-04 | 10 | 50 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.45e-04 | 10 | 50 | 2 | M27945 | |
| Pathway | WP_THERMOGENESIS | 5.72e-04 | 108 | 50 | 4 | M39746 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.10e-04 | 47 | 50 | 3 | M7946 | |
| Pathway | REACTOME_ADIPOGENESIS | 6.13e-04 | 110 | 50 | 4 | M48259 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 6.49e-04 | 48 | 50 | 3 | M219 | |
| Pathway | PID_HES_HEY_PATHWAY | 6.49e-04 | 48 | 50 | 3 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.49e-04 | 48 | 50 | 3 | M611 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.64e-04 | 11 | 50 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.64e-04 | 11 | 50 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.64e-04 | 11 | 50 | 2 | M26924 | |
| Pathway | REACTOME_HEME_SIGNALING | 6.90e-04 | 49 | 50 | 3 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.90e-04 | 49 | 50 | 3 | M618 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 7.06e-04 | 201 | 50 | 5 | M39605 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.95e-04 | 12 | 50 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.95e-04 | 12 | 50 | 2 | M27765 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.95e-04 | 12 | 50 | 2 | M27159 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 7.98e-04 | 118 | 50 | 4 | M27316 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 9.04e-04 | 122 | 50 | 4 | M29689 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 9.38e-04 | 13 | 50 | 2 | M47595 | |
| Pathway | WP_MRNA_PROCESSING | 1.02e-03 | 126 | 50 | 4 | M39406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 1.09e-03 | 14 | 50 | 2 | M47414 | |
| Pathway | REACTOME_GASTRULATION | 1.11e-03 | 129 | 50 | 4 | M46433 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.13e-03 | 58 | 50 | 3 | M29616 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | FLI1 NCOA6 ARID1B PABPN1 DAB1 SMARCC2 MAML2 PAX6 ARID1A SS18 CREBBP EP300 MED13 | 1.14e-03 | 1432 | 50 | 13 | M509 |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.26e-03 | 15 | 50 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.26e-03 | 15 | 50 | 2 | M953 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM1498 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.37e-03 | 62 | 50 | 3 | MM15426 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 1.43e-03 | 16 | 50 | 2 | M39675 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.43e-03 | 16 | 50 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.43e-03 | 16 | 50 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.43e-03 | 16 | 50 | 2 | M8516 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 1.43e-03 | 16 | 50 | 2 | M11792 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.43e-03 | 16 | 50 | 2 | M27940 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.57e-03 | 65 | 50 | 3 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.59e-03 | 142 | 50 | 4 | M48257 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.62e-03 | 17 | 50 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.62e-03 | 17 | 50 | 2 | M48025 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.71e-03 | 67 | 50 | 3 | M27694 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.82e-03 | 18 | 50 | 2 | MM14775 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.87e-03 | 69 | 50 | 3 | M46439 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.94e-03 | 70 | 50 | 3 | M938 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.03e-03 | 19 | 50 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.03e-03 | 19 | 50 | 2 | M46442 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.08e-03 | 153 | 50 | 4 | MM15522 | |
| Pubmed | FLI1 BCL9L NCOA6 ZNF536 ARID1B RBM12 PBRM1 EP400 ATXN2 PABPN1 WDR33 GLI2 HGS SEC16A CSTF2 SMARCC2 ZFHX3 R3HDM2 PAX6 ZMIZ1 SSBP4 BCL9 SSBP3 ARID1A SS18 SMAP2 CREBBP CAPRIN1 PRPF40A RBM20 EP300 TAB3 TBP | 1.27e-28 | 1429 | 65 | 33 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L FNDC3B NCOA6 ARID1B RBM12 ATXN2 WDR33 GLI1 SEC23IP SEC16A FNDC3A ZMIZ1 BCL9 ARID1A PSPC1 CREBBP PRPF40A RBM20 EP300 | 8.73e-21 | 457 | 65 | 19 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | FLI1 BCL9L NCOA6 ZNF536 ARID1B PBRM1 EP400 SEC16A SMARCC2 ZFHX3 ZMIZ1 BCL9 ARID1A CREBBP EP300 | 1.12e-16 | 351 | 65 | 15 | 38297188 |
| Pubmed | RBM12 WDR33 R3HDM2 ZMIZ1 BCL9 SSBP3 PSPC1 CREBBP SF1 EP300 TAB3 | 5.62e-15 | 152 | 65 | 11 | 38360978 | |
| Pubmed | BCL9L NCOA6 ARID1B RBM12 PBRM1 EP400 WDR33 SMARCC2 BCL9 ARID1A CREBBP MED13 | 9.60e-14 | 268 | 65 | 12 | 33640491 | |
| Pubmed | 1.66e-13 | 15 | 65 | 6 | 23785148 | ||
| Pubmed | NCOA6 ARID1B PBRM1 EP400 SMARCC2 PAX6 ARID1A SS18 CREBBP EP300 | 3.80e-13 | 157 | 65 | 10 | 30186101 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 3.31e-12 | 23 | 65 | 6 | 30962207 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 ARID1B EP400 ATXN2 WDR33 SEC16A CSTF2 SMARCC2 DLX1 ARID1A SNRPA PSPC1 SS18 PRPF40A PICALM SF1 | 1.67e-11 | 954 | 65 | 16 | 36373674 |
| Pubmed | BCL9L NCOA6 PABPN1 CSTF2 SMARCC2 BCL9 ARID1A SNRPA CREBBP PRPF40A EP300 CREB5 | 2.13e-11 | 425 | 65 | 12 | 24999758 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 3.85e-11 | 14 | 65 | 5 | 36289231 | |
| Pubmed | ATF7 FLI1 NCOA6 ARID1B RBM12 EP400 ATXN2 SMARCC2 BCL9 ARID1A SNRPA PSPC1 CREBBP CAPRIN1 SF1 EP300 | 1.42e-10 | 1103 | 65 | 16 | 34189442 | |
| Pubmed | ZNF536 ARID1B ARHGEF33 PBRM1 EP400 RTL9 SEC16A ADNP2 SMARCC2 ZFHX3 ARID1A SS18 CREBBP PRPF40A EP300 TBP | 1.68e-10 | 1116 | 65 | 16 | 31753913 | |
| Pubmed | RBM12 ATXN2 WDR33 SEC16A CSTF2 SMARCC2 SNRPA PSPC1 CAPRIN1 PRPF40A SF1 | 2.03e-10 | 399 | 65 | 11 | 35987950 | |
| Pubmed | 2.12e-10 | 83 | 65 | 7 | 28794006 | ||
| Pubmed | NCOA6 ARID1B EP400 WDR33 SEC23IP SEC16A CSTF2 ARID1A CREBBP PRPF40A EP300 TAB3 | 4.00e-10 | 549 | 65 | 12 | 38280479 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 5.01e-10 | 154 | 65 | 8 | 16055720 | |
| Pubmed | 1.52e-09 | 27 | 65 | 5 | 29374058 | ||
| Pubmed | 2.55e-09 | 65 | 65 | 6 | 26655900 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ARID1B PBRM1 EP400 SEC16A ADNP2 SMARCC2 ARID1A CREBBP RBM20 EP300 | 3.52e-09 | 398 | 65 | 10 | 35016035 |
| Pubmed | 3.77e-09 | 32 | 65 | 5 | 19542561 | ||
| Pubmed | ATF7 RBM12 PBRM1 EP400 PABPN1 CSTF2 SMARCC2 SNRPA PSPC1 CREBBP PRPF40A SF1 EP300 MED13 | 4.49e-09 | 1014 | 65 | 14 | 32416067 | |
| Pubmed | 5.44e-09 | 12 | 65 | 4 | 11734557 | ||
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 9590171 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.36e-09 | 220 | 65 | 8 | 35785414 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.22e-08 | 40 | 65 | 5 | 34585037 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 8995708 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 9194565 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 2.60e-08 | 17 | 65 | 4 | 12368262 | |
| Pubmed | 2.60e-08 | 17 | 65 | 4 | 11078522 | ||
| Pubmed | NCOA6 ZNF536 ARID1B PBRM1 SEC23IP SMARCC2 BCL9 ARID1A SS18 CREBBP EP300 | 2.65e-08 | 638 | 65 | 11 | 31182584 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.88e-08 | 258 | 65 | 8 | 37794589 | |
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 3.87e-08 | 50 | 65 | 5 | 27716508 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 4.22e-08 | 19 | 65 | 4 | 12110891 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 4.78e-08 | 180 | 65 | 7 | 30110629 | |
| Pubmed | Human p300 protein is a coactivator for the transcription factor MyoD. | 6.21e-08 | 5 | 65 | 3 | 8621548 | |
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 6.21e-08 | 5 | 65 | 3 | 12672490 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 11912212 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ARID1B NPTX2 EP400 PABPN1 WDR33 CSTF2 SMARCC2 ARID1A SNRPA PSPC1 PRPF40A SF1 HCRTR1 | 8.73e-08 | 1082 | 65 | 13 | 38697112 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATF7 NCOA6 YIPF5 PBRM1 EP400 PABPN1 WDR33 CSTF2 PAX6 ARID1A SNRPA PRPF40A SF1 EP300 | 9.39e-08 | 1294 | 65 | 14 | 30804502 |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 9.58e-08 | 23 | 65 | 4 | 8804307 | |
| Pubmed | 1.07e-07 | 61 | 65 | 5 | 20305087 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.08e-07 | 430 | 65 | 9 | 35044719 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.09e-07 | 203 | 65 | 7 | 22083510 | |
| Pubmed | 1.15e-07 | 24 | 65 | 4 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 1.15e-07 | 24 | 65 | 4 | 10078207 | |
| Pubmed | 1.15e-07 | 24 | 65 | 4 | 12215535 | ||
| Pubmed | Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes. | 1.24e-07 | 6 | 65 | 3 | 19650111 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 27585885 | ||
| Pubmed | Variation of tooth number in mammalian dentition: connecting genetics, development, and evolution. | 1.24e-07 | 6 | 65 | 3 | 12752768 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 16230384 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 1.24e-07 | 6 | 65 | 3 | 25184676 | |
| Pubmed | Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | 1.24e-07 | 6 | 65 | 3 | 15961999 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 26871568 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.41e-07 | 444 | 65 | 9 | 34795231 | |
| Pubmed | 1.60e-07 | 66 | 65 | 5 | 23275444 | ||
| Pubmed | 1.61e-07 | 26 | 65 | 4 | 26387942 | ||
| Pubmed | 1.61e-07 | 26 | 65 | 4 | 10778858 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 23540691 | ||
| Pubmed | 2.20e-07 | 28 | 65 | 4 | 30037996 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 2.20e-07 | 28 | 65 | 4 | 12192000 | |
| Pubmed | 2.36e-07 | 472 | 65 | 9 | 38943005 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.44e-07 | 341 | 65 | 8 | 32971831 | |
| Pubmed | 2.55e-07 | 29 | 65 | 4 | 36800290 | ||
| Pubmed | 2.55e-07 | 29 | 65 | 4 | 19279220 | ||
| Pubmed | 2.94e-07 | 30 | 65 | 4 | 31043422 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 36335117 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 22265416 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.90e-07 | 150 | 65 | 6 | 28242625 | |
| Pubmed | The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription. | 5.19e-07 | 9 | 65 | 3 | 14612417 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 23556151 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 5.19e-07 | 9 | 65 | 3 | 20086098 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 37805104 | ||
| Pubmed | Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. | 5.19e-07 | 9 | 65 | 3 | 12361967 | |
| Pubmed | The loss of Hh responsiveness by a non-ciliary Gli2 variant. | 5.19e-07 | 9 | 65 | 3 | 25834022 | |
| Pubmed | 5.57e-07 | 35 | 65 | 4 | 32504627 | ||
| Pubmed | 6.25e-07 | 263 | 65 | 7 | 34702444 | ||
| Pubmed | 7.00e-07 | 37 | 65 | 4 | 24335282 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 7.32e-07 | 167 | 65 | 6 | 20362541 | |
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 19549984 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 7.41e-07 | 10 | 65 | 3 | 16751102 | |
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 38358805 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 12665591 | ||
| Pubmed | Spatial pattern of sonic hedgehog signaling through Gli genes during cerebellum development. | 7.41e-07 | 10 | 65 | 3 | 15496441 | |
| Pubmed | FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. | 7.41e-07 | 10 | 65 | 3 | 9171351 | |
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 27849569 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 15736266 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 11748151 | ||
| Pubmed | Developmental diversification of cortical inhibitory interneurons. | 8.01e-07 | 91 | 65 | 5 | 29513653 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 9.96e-07 | 411 | 65 | 8 | 35182466 | |
| Pubmed | 1.02e-06 | 11 | 65 | 3 | 10454579 | ||
| Pubmed | Complementary Gli activity mediates early patterning of the mouse visual system. | 1.02e-06 | 11 | 65 | 3 | 16342201 | |
| Pubmed | CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder. | 1.02e-06 | 11 | 65 | 3 | 36385105 | |
| Pubmed | Distinct Activities of Gli1 and Gli2 in the Absence of Ift88 and the Primary Cilia. | 1.02e-06 | 11 | 65 | 3 | 30791390 | |
| Pubmed | 1.02e-06 | 11 | 65 | 3 | 24038357 | ||
| Pubmed | 1.02e-06 | 11 | 65 | 3 | 26965372 | ||
| Pubmed | 1.02e-06 | 11 | 65 | 3 | 18003620 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.06e-06 | 178 | 65 | 6 | 27637333 | |
| Pubmed | PBRM1 EP400 ATXN2 PABPN1 WDR33 SEC16A DAB1 SMARCC2 PSPC1 CAPRIN1 PRPF40A SF1 MX2 | 1.28e-06 | 1371 | 65 | 13 | 36244648 | |
| Pubmed | 1.35e-06 | 12 | 65 | 3 | 12189208 | ||
| Interaction | SP7 interactions | FLI1 BCL9L NCOA6 ZNF536 ARID1B RBM12 PBRM1 EP400 WDR33 SMARCC2 DLX1 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP PRPF40A RBM20 EP300 | 3.06e-21 | 304 | 65 | 20 | int:SP7 |
| Interaction | NUP35 interactions | BCL9L FNDC3B NCOA6 ARID1B RBM12 ATXN2 WDR33 GLI1 SEC23IP SEC16A FNDC3A ZMIZ1 BCL9 ARID1A PSPC1 CREBBP PRPF40A RBM20 EP300 | 4.66e-17 | 424 | 65 | 19 | int:NUP35 |
| Interaction | CRX interactions | FLI1 BCL9L ZNF536 ARID1B PBRM1 EP400 HGS ZFHX3 ZMIZ1 BCL9 ARID1A SMAP2 CREBBP PICALM EP300 | 2.51e-15 | 254 | 65 | 15 | int:CRX |
| Interaction | SS18L1 interactions | ARID1B PBRM1 HGS CSTF2 SMARCC2 PAX6 SSBP3 ARID1A SS18 CREBBP EP300 | 1.45e-14 | 98 | 65 | 11 | int:SS18L1 |
| Interaction | ALG13 interactions | ARID1B RBM12 ATXN2 WDR33 SEC16A R3HDM2 BCL9 ARID1A SMAP2 PRPF40A RBM20 SF1 EP300 | 2.02e-14 | 183 | 65 | 13 | int:ALG13 |
| Interaction | LHX2 interactions | BCL9L ZNF536 ARID1B PBRM1 EP400 SMARCC2 ZFHX3 PAX6 SSBP4 BCL9 SSBP3 ARID1A SS18 | 2.02e-14 | 183 | 65 | 13 | int:LHX2 |
| Interaction | AR interactions | BCL9L NCOA6 ARID1B RBM12 PBRM1 CACUL1 EP400 WDR33 GLI2 SEC16A SMARCC2 ZFHX3 PAX6 ZMIZ1 BCL9 ARID1A PSPC1 CREBBP PRPF40A EP300 MED13 TBP | 2.16e-13 | 992 | 65 | 22 | int:AR |
| Interaction | EGR2 interactions | FLI1 BCL9L NCOA6 ZNF536 ARID1B EP400 SEC16A ZFHX3 BCL9 ARID1A CREBBP EP300 | 2.57e-13 | 171 | 65 | 12 | int:EGR2 |
| Interaction | SOX9 interactions | NCOA6 ARID1B PBRM1 EP400 SMARCC2 PAX6 BCL9 ARID1A CREBBP EP300 | 5.97e-13 | 97 | 65 | 10 | int:SOX9 |
| Interaction | TLE3 interactions | BCL9L ARID1B RBM12 GLI2 CSTF2 SMARCC2 ZFHX3 PAX6 ZMIZ1 SSBP4 BCL9 ARID1A CREBBP RBM20 EP300 | 7.78e-13 | 376 | 65 | 15 | int:TLE3 |
| Interaction | ETV4 interactions | 1.03e-12 | 69 | 65 | 9 | int:ETV4 | |
| Interaction | KLF5 interactions | NCOA6 ARID1B PBRM1 EP400 SEC16A BCL9 ARID1A SS18 CREBBP RBM20 EP300 TBP | 1.23e-12 | 195 | 65 | 12 | int:KLF5 |
| Interaction | GATA2 interactions | NCOA6 ZNF536 ARID1B PBRM1 SMARCC2 ZFHX3 BCL9 SSBP3 ARID1A SS18 CREBBP EP300 | 1.57e-12 | 199 | 65 | 12 | int:GATA2 |
| Interaction | TBR1 interactions | MST1R BCL9L ZNF536 ARID1B ZFHX3 ZMIZ1 BCL9 SSBP3 ARID1A EP300 | 2.83e-12 | 113 | 65 | 10 | int:TBR1 |
| Interaction | TBXT interactions | NCOA6 ZNF536 ARID1B SMARCC2 BCL9 SSBP3 ARID1A SS18 CREBBP EP300 | 3.69e-12 | 116 | 65 | 10 | int:TBXT |
| Interaction | PAX7 interactions | 7.24e-12 | 124 | 65 | 10 | int:PAX7 | |
| Interaction | PAX6 interactions | NCOA6 ZNF536 ARID1B PBRM1 EP400 HGS SMARCC2 ZFHX3 PAX6 BCL9 ARID1A CREBBP EP300 TBP | 8.75e-12 | 366 | 65 | 14 | int:PAX6 |
| Interaction | PAX9 interactions | FLI1 BCL9L NCOA6 ZNF536 ARID1B PBRM1 ZFHX3 BCL9 ARID1A EP300 | 1.16e-11 | 130 | 65 | 10 | int:PAX9 |
| Interaction | FOS interactions | ATF7 NCOA6 ARID1B PBRM1 EP400 SMARCC2 BCL9 ARID1A SS18 CREBBP EP300 CREB5 TBP | 1.83e-11 | 312 | 65 | 13 | int:FOS |
| Interaction | GCM1 interactions | 4.76e-11 | 68 | 65 | 8 | int:GCM1 | |
| Interaction | SMARCC2 interactions | FLI1 ARID1B PBRM1 GLI1 SMARCC2 PAX6 SSBP3 ARID1A SS18 CREBBP CAPRIN1 PRPF40A EP300 | 8.48e-11 | 353 | 65 | 13 | int:SMARCC2 |
| Interaction | DDIT3 interactions | 1.68e-10 | 120 | 65 | 9 | int:DDIT3 | |
| Interaction | FUS interactions | FLI1 FNDC3B NCOA6 PBRM1 PABPN1 WDR33 CSTF2 SMARCC2 ARID1A SNRPA PSPC1 SS18 CREBBP CAPRIN1 PICALM SF1 EP300 | 1.70e-10 | 757 | 65 | 17 | int:FUS |
| Interaction | GATA1 interactions | FLI1 ARID1B RBM12 SMARCC2 BCL9 ARID1A CREBBP PRPF40A RBM20 EP300 | 1.78e-10 | 171 | 65 | 10 | int:GATA1 |
| Interaction | ETS1 interactions | 1.81e-10 | 121 | 65 | 9 | int:ETS1 | |
| Interaction | SMARCA4 interactions | FLI1 ARID1B PBRM1 EP400 PABPN1 GLI1 SMARCC2 PAX6 SSBP3 ARID1A SS18 CREBBP PRPF40A EP300 | 1.91e-10 | 462 | 65 | 14 | int:SMARCA4 |
| Interaction | SOX7 interactions | 2.22e-10 | 82 | 65 | 8 | int:SOX7 | |
| Interaction | EYA4 interactions | RBM12 WDR33 R3HDM2 ZMIZ1 BCL9 SSBP3 PSPC1 CREBBP SF1 EP300 TAB3 | 3.15e-10 | 243 | 65 | 11 | int:EYA4 |
| Interaction | GSC interactions | 3.59e-10 | 87 | 65 | 8 | int:GSC | |
| Interaction | SMG7 interactions | NCOA6 ARID1B RBM12 ATXN2 SEC16A R3HDM2 BCL9 ARID1A SMAP2 CREBBP CAPRIN1 RBM20 | 3.83e-10 | 319 | 65 | 12 | int:SMG7 |
| Interaction | GATA3 interactions | ZNF536 ARID1B RBM12 PBRM1 BCL9 ARID1A CREBBP PRPF40A RBM20 EP300 | 4.28e-10 | 187 | 65 | 10 | int:GATA3 |
| Interaction | HNF1B interactions | ZNF536 ARID1B PBRM1 EP400 ZFHX3 PAX6 BCL9 ARID1A CREBBP EP300 | 5.00e-10 | 190 | 65 | 10 | int:HNF1B |
| Interaction | MYOD1 interactions | ARID1B PBRM1 EP400 PABPN1 SMARCC2 BCL9 ARID1A SS18 CREBBP EP300 | 6.12e-10 | 194 | 65 | 10 | int:MYOD1 |
| Interaction | FEV interactions | NCOA6 ARID1B PBRM1 EP400 ZFHX3 BCL9 SSBP3 ARID1A CREBBP EP300 | 9.52e-10 | 203 | 65 | 10 | int:FEV |
| Interaction | SOX2 interactions | FLI1 BCL9L NCOA6 ZNF536 ARID1B C2CD3 PBRM1 EP400 PABPN1 SEC16A SMARCC2 ZFHX3 DLX1 PAX6 BCL9 SSBP3 ARID1A SS18 CAPRIN1 PICALM EP300 | 1.71e-09 | 1422 | 65 | 21 | int:SOX2 |
| Interaction | SMARCE1 interactions | FLI1 ARID1B PBRM1 GLI1 SMARCC2 PAX6 SSBP3 ARID1A SS18 PRPF40A EP300 | 1.83e-09 | 287 | 65 | 11 | int:SMARCE1 |
| Interaction | ERG interactions | FLI1 NCOA6 ARID1B SMARCC2 BCL9 ARID1A SS18 CREBBP PRPF40A EP300 | 2.37e-09 | 223 | 65 | 10 | int:ERG |
| Interaction | EWSR1 interactions | FLI1 BCL9L NCOA6 PABPN1 CSTF2 SMARCC2 BCL9 SSBP3 ARID1A SNRPA PSPC1 CREBBP PRPF40A PICALM SF1 EP300 CREB5 | 2.63e-09 | 906 | 65 | 17 | int:EWSR1 |
| Interaction | TLX1 interactions | 4.81e-09 | 175 | 65 | 9 | int:TLX1 | |
| Interaction | TEAD1 interactions | 5.06e-09 | 176 | 65 | 9 | int:TEAD1 | |
| Interaction | IRF1 interactions | 8.92e-09 | 83 | 65 | 7 | int:IRF1 | |
| Interaction | PRRC2B interactions | ATXN2 SEC16A R3HDM2 PAX6 PSPC1 SMAP2 CAPRIN1 PICALM RBM20 SF1 | 1.24e-08 | 265 | 65 | 10 | int:PRRC2B |
| Interaction | SS18 interactions | 1.35e-08 | 88 | 65 | 7 | int:SS18 | |
| Interaction | SMAD3 interactions | FLI1 NCOA6 ARID1B HGS SMARCC2 ZFHX3 PAX6 ZMIZ1 ARID1A PSPC1 CREBBP EP300 | 1.70e-08 | 447 | 65 | 12 | int:SMAD3 |
| Interaction | HNF4A interactions | NCOA6 ARID1B PBRM1 EP400 SMARCC2 ARID1A SS18 CREBBP EP300 TBP | 1.76e-08 | 275 | 65 | 10 | int:HNF4A |
| Interaction | FOXI1 interactions | 1.84e-08 | 92 | 65 | 7 | int:FOXI1 | |
| Interaction | DAZL interactions | 2.11e-08 | 145 | 65 | 8 | int:DAZL | |
| Interaction | SMARCB1 interactions | FLI1 ARID1B PBRM1 GLI1 HGS SMARCC2 PAX6 ARID1A SS18 CREBBP EP300 | 2.15e-08 | 364 | 65 | 11 | int:SMARCB1 |
| Interaction | CIITA interactions | 2.28e-08 | 55 | 65 | 6 | int:CIITA | |
| Interaction | PIAS3 interactions | 2.30e-08 | 95 | 65 | 7 | int:PIAS3 | |
| Interaction | ACTL6A interactions | FLI1 ARID1B PBRM1 EP400 SMARCC2 FNDC3A ARID1A SS18 SF1 EP300 | 2.81e-08 | 289 | 65 | 10 | int:ACTL6A |
| Interaction | LHX6 interactions | 3.16e-08 | 58 | 65 | 6 | int:LHX6 | |
| Interaction | ARID2 interactions | 3.21e-08 | 153 | 65 | 8 | int:ARID2 | |
| Interaction | FUBP3 interactions | RBM12 ATXN2 SEC16A R3HDM2 PSPC1 SMAP2 CAPRIN1 RBM20 SF1 EP300 | 3.64e-08 | 297 | 65 | 10 | int:FUBP3 |
| Interaction | SMARCC1 interactions | FLI1 ARID1B PBRM1 SMARCC2 PAX6 ARID1A SS18 CREBBP CAPRIN1 PRPF40A EP300 | 3.71e-08 | 384 | 65 | 11 | int:SMARCC1 |
| Interaction | FLI1 interactions | 4.74e-08 | 62 | 65 | 6 | int:FLI1 | |
| Interaction | SMARCD3 interactions | 5.27e-08 | 107 | 65 | 7 | int:SMARCD3 | |
| Interaction | LHX4 interactions | 6.06e-08 | 166 | 65 | 8 | int:LHX4 | |
| Interaction | PAX8 interactions | 6.80e-08 | 111 | 65 | 7 | int:PAX8 | |
| Interaction | BICRA interactions | 7.61e-08 | 67 | 65 | 6 | int:BICRA | |
| Interaction | SMC5 interactions | NCOA6 ARID1B EP400 ATXN2 WDR33 SEC16A CSTF2 SMARCC2 DLX1 ARID1A SNRPA PSPC1 SS18 PRPF40A PICALM SF1 | 7.83e-08 | 1000 | 65 | 16 | int:SMC5 |
| Interaction | LDB1 interactions | 8.68e-08 | 115 | 65 | 7 | int:LDB1 | |
| Interaction | WWTR1 interactions | NCOA6 ARID1B EP400 SEC23IP SEC16A CSTF2 ARID1A CREBBP PRPF40A EP300 TAB3 | 9.66e-08 | 422 | 65 | 11 | int:WWTR1 |
| Interaction | ARID1B interactions | 9.95e-08 | 177 | 65 | 8 | int:ARID1B | |
| Interaction | KLF1 interactions | 1.20e-07 | 37 | 65 | 5 | int:KLF1 | |
| Interaction | LHX3 interactions | 1.40e-07 | 185 | 65 | 8 | int:LHX3 | |
| Interaction | SMARCA2 interactions | 1.51e-07 | 346 | 65 | 10 | int:SMARCA2 | |
| Interaction | ARID1A interactions | 2.43e-07 | 276 | 65 | 9 | int:ARID1A | |
| Interaction | PHF10 interactions | 3.18e-07 | 139 | 65 | 7 | int:PHF10 | |
| Interaction | IRF4 interactions | 3.19e-07 | 85 | 65 | 6 | int:IRF4 | |
| Interaction | CELF1 interactions | 3.48e-07 | 288 | 65 | 9 | int:CELF1 | |
| Interaction | SOX15 interactions | 3.51e-07 | 141 | 65 | 7 | int:SOX15 | |
| Interaction | KLF15 interactions | 3.69e-07 | 290 | 65 | 9 | int:KLF15 | |
| Interaction | TLX3 interactions | 3.80e-07 | 291 | 65 | 9 | int:TLX3 | |
| Interaction | HSF1 interactions | BCL9L NCOA6 EP400 ATXN2 PABPN1 RTL9 SEC16A NEK7 CREBBP PRPF40A EP300 TBP | 4.85e-07 | 609 | 65 | 12 | int:HSF1 |
| Interaction | SOX10 interactions | 5.10e-07 | 92 | 65 | 6 | int:SOX10 | |
| Interaction | SOX17 interactions | 6.17e-07 | 95 | 65 | 6 | int:SOX17 | |
| Interaction | DPF3 interactions | 6.17e-07 | 95 | 65 | 6 | int:DPF3 | |
| Interaction | DPF1 interactions | 6.17e-07 | 95 | 65 | 6 | int:DPF1 | |
| Interaction | NFIX interactions | 6.66e-07 | 227 | 65 | 8 | int:NFIX | |
| Interaction | KLF3 interactions | 6.88e-07 | 228 | 65 | 8 | int:KLF3 | |
| Interaction | CNOT9 interactions | 7.59e-07 | 231 | 65 | 8 | int:CNOT9 | |
| Interaction | RUNX1 interactions | 9.31e-07 | 324 | 65 | 9 | int:RUNX1 | |
| Interaction | TP53BP1 interactions | NCOA6 ARID1B EP400 HGS SMARCC2 ARID1A PSPC1 CREBBP EP300 MED13 CREB5 | 9.83e-07 | 533 | 65 | 11 | int:TP53BP1 |
| Interaction | LHX1 interactions | 9.96e-07 | 103 | 65 | 6 | int:LHX1 | |
| Interaction | TPRX2 interactions | 1.00e-06 | 56 | 65 | 5 | int:TPRX2 | |
| Interaction | SSBP4 interactions | 1.31e-06 | 59 | 65 | 5 | int:SSBP4 | |
| Interaction | WBP4 interactions | 1.39e-06 | 109 | 65 | 6 | int:WBP4 | |
| Interaction | CEBPA interactions | ATF7 FLI1 NCOA6 ARID1B RBM12 EP400 ATXN2 SMARCC2 BCL9 ARID1A SNRPA PSPC1 CREBBP CAPRIN1 SF1 EP300 | 1.49e-06 | 1245 | 65 | 16 | int:CEBPA |
| Interaction | DPF2 interactions | 1.72e-06 | 349 | 65 | 9 | int:DPF2 | |
| Interaction | PBRM1 interactions | 1.74e-06 | 258 | 65 | 8 | int:PBRM1 | |
| Interaction | HDAC1 interactions | ZNF536 EP400 GLI1 GLI2 SEC23IP SMARCC2 ZFHX3 ZMIZ1 ARID1A SS18 CREBBP CAPRIN1 RBM20 EP300 TBP | 1.79e-06 | 1108 | 65 | 15 | int:HDAC1 |
| Interaction | BCL7C interactions | 1.90e-06 | 115 | 65 | 6 | int:BCL7C | |
| Interaction | PYGO1 interactions | 1.90e-06 | 28 | 65 | 4 | int:PYGO1 | |
| Interaction | SMARCD2 interactions | 2.03e-06 | 183 | 65 | 7 | int:SMARCD2 | |
| Interaction | DDX1 interactions | MST1R ATXN2 GLI1 NEK7 CSTF2 FNDC3A R3HDM2 PSPC1 PICALM EP300 | 2.15e-06 | 463 | 65 | 10 | int:DDX1 |
| Interaction | NFIA interactions | 2.42e-06 | 188 | 65 | 7 | int:NFIA | |
| Interaction | SMAP2 interactions | 2.51e-06 | 189 | 65 | 7 | int:SMAP2 | |
| Interaction | TOP3B interactions | MST1R NCOA6 C2CD3 EP400 ATXN2 PABPN1 GLI1 SEC16A R3HDM2 SSBP4 BCL9 ARID1A SNRPA SMAP2 CAPRIN1 EP300 MED13 | 2.76e-06 | 1470 | 65 | 17 | int:TOP3B |
| Interaction | BCL7A interactions | 2.81e-06 | 123 | 65 | 6 | int:BCL7A | |
| GeneFamily | RNA binding motif containing | 1.58e-05 | 213 | 46 | 6 | 725 | |
| GeneFamily | AT-rich interaction domain containing | 6.51e-04 | 15 | 46 | 2 | 418 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.51e-04 | 15 | 46 | 2 | 529 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.41e-04 | 17 | 46 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.44e-04 | 18 | 46 | 2 | 91 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.83e-03 | 25 | 46 | 2 | 775 | |
| GeneFamily | Basic leucine zipper proteins | 6.90e-03 | 49 | 46 | 2 | 506 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.04e-03 | 53 | 46 | 2 | 532 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | C2CD3 ATXN2 NEK7 FNDC3A ZFHX3 R3HDM2 ZMIZ1 TSC22D2 CREBBP PICALM MED13 CREB5 | 1.12e-06 | 856 | 65 | 12 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.17e-06 | 466 | 65 | 9 | M13522 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 6.26e-06 | 183 | 65 | 6 | M8189 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_DN | 1.04e-05 | 200 | 65 | 6 | M3355 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN | 1.04e-05 | 200 | 65 | 6 | M8962 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 | 1.37e-05 | 19 | 65 | 3 | M13194 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.53e-05 | 323 | 65 | 7 | M9150 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.98e-05 | 467 | 65 | 8 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.56e-05 | 484 | 65 | 8 | MM999 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 4.67e-05 | 685 | 65 | 9 | MM3782 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 4.99e-05 | 389 | 65 | 7 | M6520 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLI1 RBM12 EP400 NEK7 SSBP4 ARID1A SMAP2 CREBBP PRPF40A PICALM SF1 EP300 MED13 | 6.39e-05 | 1492 | 65 | 13 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.55e-05 | 180 | 65 | 5 | M8239 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 8.97e-05 | 294 | 65 | 6 | M40873 | |
| Coexpression | OSMAN_BLADDER_CANCER_DN | 9.48e-05 | 431 | 65 | 7 | M16858 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN | 1.40e-04 | 200 | 65 | 5 | M7741 | |
| Coexpression | GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN | 1.40e-04 | 200 | 65 | 5 | M7042 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 1.40e-04 | 200 | 65 | 5 | M8690 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 1.40e-04 | 200 | 65 | 5 | M4352 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | FLI1 NCOA6 EP400 PABPN1 SEC23IP NEK7 SNRPA PRPF40A SF1 EP300 MX2 TBP | 1.43e-04 | 1394 | 65 | 12 | M9585 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 1.68e-04 | 634 | 65 | 8 | M40866 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 2.70e-04 | 680 | 65 | 8 | M41089 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.31e-05 | 209 | 65 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.65e-05 | 226 | 65 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 9.36e-05 | 149 | 65 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.24e-04 | 492 | 65 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.29e-04 | 255 | 65 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.41e-04 | 259 | 65 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.61e-04 | 89 | 65 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | FLI1 YIPF5 CACUL1 SMARCC2 ZFHX3 DLX1 PAX6 BCL9 ARID1A PRPF40A TBP | 1.88e-04 | 989 | 65 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.52e-07 | 190 | 65 | 6 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.73e-06 | 186 | 65 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.73e-06 | 186 | 65 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.24e-06 | 193 | 65 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.24e-06 | 193 | 65 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.96e-06 | 196 | 65 | 5 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 197 | 65 | 5 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 65 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-05 | 110 | 65 | 4 | 854f21560ce7cb5e1923403b6d04df3d804431e2 | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-04 | 170 | 65 | 4 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 171 | 65 | 4 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 177 | 65 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-04 | 177 | 65 | 4 | 6f3b254e56e722cc23495b49e99a4abce0243cb3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 178 | 65 | 4 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | (08)_PNEC-(4)_1wkpi|(08)_PNEC / shred by cell type and Timepoint | 1.34e-04 | 12 | 65 | 2 | f1b105bcdbe03be6765c820b42c752a24d502212 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 181 | 65 | 4 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 181 | 65 | 4 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 181 | 65 | 4 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 182 | 65 | 4 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 182 | 65 | 4 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 182 | 65 | 4 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 183 | 65 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 183 | 65 | 4 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 183 | 65 | 4 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 183 | 65 | 4 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 184 | 65 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 184 | 65 | 4 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 185 | 65 | 4 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 185 | 65 | 4 | 0149981d3818a6250f32c08456c28e7037c39d91 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 185 | 65 | 4 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-04 | 185 | 65 | 4 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 186 | 65 | 4 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 1.57e-04 | 186 | 65 | 4 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 186 | 65 | 4 | 76535681667c8afb884fa72b6edfee9e1e46335b | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 186 | 65 | 4 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 186 | 65 | 4 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.57e-04 | 186 | 65 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.60e-04 | 187 | 65 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 187 | 65 | 4 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 187 | 65 | 4 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | control-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.64e-04 | 188 | 65 | 4 | 22d76c222fb0e3da08e10191af0090f14e03f2ad | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 188 | 65 | 4 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 188 | 65 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 16a4c92dd7a0d60f3691bd3130a091a9a54730f1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-04 | 189 | 65 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-04 | 189 | 65 | 4 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 189 | 65 | 4 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 189 | 65 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.71e-04 | 190 | 65 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 190 | 65 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 191 | 65 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.78e-04 | 192 | 65 | 4 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 192 | 65 | 4 | 3fc7a661ef39286abfd82ed8ab580011f01cb8fd | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.81e-04 | 193 | 65 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 193 | 65 | 4 | 4f4f430d7e1b65e19ca829f55ca93edeb6c1c85d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 193 | 65 | 4 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 193 | 65 | 4 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.85e-04 | 194 | 65 | 4 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 194 | 65 | 4 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.88e-04 | 195 | 65 | 4 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 195 | 65 | 4 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.92e-04 | 196 | 65 | 4 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.92e-04 | 196 | 65 | 4 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | mild-Myeloid-Neutrophils_4|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.92e-04 | 196 | 65 | 4 | f8c98cded5550843322b1711e1a57c7e88cae861 | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-04 | 196 | 65 | 4 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.92e-04 | 196 | 65 | 4 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.92e-04 | 196 | 65 | 4 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 | |
| ToppCell | proximal-mesenchymal-Myofibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.96e-04 | 197 | 65 | 4 | ab21baea931ff134cf5a7ee369c091230988108b | |
| ToppCell | proximal-mesenchymal-Myofibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.96e-04 | 197 | 65 | 4 | 15f2f169758a07143fc7d1bdb58d0b4d750a0be4 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-04 | 197 | 65 | 4 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | proximal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.96e-04 | 197 | 65 | 4 | c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 198 | 65 | 4 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | control-Myeloid|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.00e-04 | 198 | 65 | 4 | abf08cde20c1843d54ba008c1db5a6ab376c761e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-04 | 198 | 65 | 4 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 2.00e-04 | 198 | 65 | 4 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | f1d5808ccb1d5d4e2d34f864e705e2484000e88f | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.04e-04 | 199 | 65 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.04e-04 | 199 | 65 | 4 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 199 | 65 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | COVID-19_Severe-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 2.04e-04 | 199 | 65 | 4 | e4d8bf016fd95a440e30014a75587e097e90cfad | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 200 | 65 | 4 | de55100e98d3e9b8a74e37aebcd3afa2b0996527 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 978dfb3c1d5e1c3d778a089175c50b8b719626c0 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | d28b27776c46054b01bdd1e0f1db7c5cd5a48b88 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 200 | 65 | 4 | 553e9612874480f4d2a45671462e266cd0a09321 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | b4277b6faa69f20974696c7c422311f5c89e3663 | |
| ToppCell | mild-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.62e-04 | 95 | 65 | 3 | 74df0149882e2cd0d9aba0ef1ae4aac2cc1aeeac | |
| Drug | ipronidazole | 8.03e-06 | 2 | 65 | 2 | CID000026951 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.10e-06 | 170 | 65 | 6 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 9.73e-06 | 172 | 65 | 6 | 1072_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 1.98e-05 | 195 | 65 | 6 | 1575_UP | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.92e-06 | 41 | 64 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.92e-06 | 41 | 64 | 4 | C0858252 | |
| Disease | Coffin-Siris syndrome | 2.74e-06 | 13 | 64 | 3 | C0265338 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.20e-06 | 195 | 64 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Menke-Hennekam syndrome | 4.63e-06 | 2 | 64 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 4.63e-06 | 2 | 64 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 4.63e-06 | 2 | 64 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 4.63e-06 | 2 | 64 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 4.63e-06 | 2 | 64 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 4.63e-06 | 2 | 64 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 4.63e-06 | 2 | 64 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 4.63e-06 | 2 | 64 | 2 | C0035934 | |
| Disease | testosterone measurement | NCOA6 ZNF536 ARID1B RTL9 SEC23IP DGKI ZFHX3 R3HDM2 ZMIZ1 TSC22D2 ARID1A SS18 | 1.65e-05 | 1275 | 64 | 12 | EFO_0004908 |
| Disease | colorectal cancer (is_marker_for) | 2.37e-05 | 157 | 64 | 5 | DOID:9256 (is_marker_for) | |
| Disease | neutrophil count | MST1R ATF7 ATXN2 WDR33 NEK7 ZMIZ1 SSBP4 BCL9 ARID1A CREBBP CREB5 HCRTR1 | 3.64e-05 | 1382 | 64 | 12 | EFO_0004833 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.61e-05 | 5 | 64 | 2 | C3281201 | |
| Disease | Psychotic Disorders | 7.02e-05 | 101 | 64 | 4 | C0033975 | |
| Disease | Carcinoma, Transitional Cell | 9.78e-05 | 41 | 64 | 3 | C0007138 | |
| Disease | diastolic blood pressure, systolic blood pressure | 9.79e-05 | 670 | 64 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Acute Promyelocytic Leukemia | 1.38e-04 | 46 | 64 | 3 | C0023487 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.47e-04 | 47 | 64 | 3 | C3179349 | |
| Disease | puberty onset measurement | 1.60e-04 | 125 | 64 | 4 | EFO_0005677 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 1.65e-04 | 9 | 64 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.65e-04 | 9 | 64 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Tumors | 1.77e-04 | 50 | 64 | 3 | C0238198 | |
| Disease | monocyte percentage of leukocytes | 1.78e-04 | 731 | 64 | 8 | EFO_0007989 | |
| Disease | TPE interval measurement | 1.99e-04 | 52 | 64 | 3 | EFO_0004644 | |
| Disease | neuroblastoma (is_implicated_in) | 2.06e-04 | 10 | 64 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Parkinson disease, late-onset | 2.06e-04 | 10 | 64 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 2.06e-04 | 10 | 64 | 2 | 168600 | |
| Disease | granulocyte count | 2.29e-04 | 254 | 64 | 5 | EFO_0007987 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.36e-04 | 55 | 64 | 3 | C0079744 | |
| Disease | risk-taking behaviour | 2.40e-04 | 764 | 64 | 8 | EFO_0008579 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.41e-04 | 139 | 64 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 2.47e-04 | 140 | 64 | 4 | C0005695 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 2.52e-04 | 11 | 64 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | Malignant neoplasm of urinary bladder | 2.54e-04 | 141 | 64 | 4 | C0005684 | |
| Disease | C-reactive protein measurement | MST1R NCOA6 ZNF536 SEC16A NEK7 SMARCC2 R3HDM2 ZMIZ1 SSBP4 HCRTR1 | 2.55e-04 | 1206 | 64 | 10 | EFO_0004458 |
| Disease | age at menarche | 2.98e-04 | 594 | 64 | 7 | EFO_0004703 | |
| Disease | Secondary Open Angle Glaucoma | 3.01e-04 | 12 | 64 | 2 | C0271148 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 3.01e-04 | 12 | 64 | 2 | C3160718 | |
| Disease | Glaucoma, Open-Angle | 3.01e-04 | 12 | 64 | 2 | C0017612 | |
| Disease | Glaucoma, Primary Open Angle | 3.56e-04 | 13 | 64 | 2 | C0339573 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 3.69e-04 | 64 | 64 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | T-Cell Lymphoma | 5.45e-04 | 16 | 64 | 2 | C0079772 | |
| Disease | ischemia (implicated_via_orthology) | 6.17e-04 | 17 | 64 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | basophil count | 6.27e-04 | 483 | 64 | 6 | EFO_0005090 | |
| Disease | Schizophrenia | 6.27e-04 | 883 | 64 | 8 | C0036341 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 7.73e-04 | 19 | 64 | 2 | DOID:4928 (is_marker_for) | |
| Disease | non-high density lipoprotein cholesterol measurement | 8.79e-04 | 713 | 64 | 7 | EFO_0005689 | |
| Disease | Nasopharyngeal carcinoma | 1.04e-03 | 22 | 64 | 2 | C2931822 | |
| Disease | Parkinson disease | 1.04e-03 | 22 | 64 | 2 | cv:C0030567 | |
| Disease | brain measurement, neuroimaging measurement | 1.23e-03 | 550 | 64 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.24e-03 | 24 | 64 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.24e-03 | 24 | 64 | 2 | C3805278 | |
| Disease | S-warfarin measurement | 1.24e-03 | 97 | 64 | 3 | EFO_0803323 | |
| Disease | vital capacity | 1.34e-03 | 1236 | 64 | 9 | EFO_0004312 | |
| Disease | Adenoid Cystic Carcinoma | 1.35e-03 | 100 | 64 | 3 | C0010606 | |
| Disease | Vitiligo | 1.39e-03 | 101 | 64 | 3 | EFO_0004208 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.42e-03 | 566 | 64 | 6 | EFO_0007660, EFO_0008354 | |
| Disease | Cholangiocarcinoma | 1.46e-03 | 26 | 64 | 2 | C0206698 | |
| Disease | alkaline phosphatase measurement | 1.53e-03 | 1015 | 64 | 8 | EFO_0004533 | |
| Disease | Sezary Syndrome | 1.57e-03 | 27 | 64 | 2 | C0036920 | |
| Disease | neutrophil percentage of leukocytes | 2.07e-03 | 610 | 64 | 6 | EFO_0007990 | |
| Disease | melanoma | 2.08e-03 | 248 | 64 | 4 | C0025202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVSMNPGPNMGQPQP | 666 | Q09472 | |
| PGPNMGQPQPGMTSN | 671 | Q09472 | |
| EPGMGPTGMQQQPPW | 1981 | Q09472 | |
| PQPQQLQSGMPRPAM | 2001 | Q09472 | |
| MPQGQPGLQPPTMPG | 2106 | Q09472 | |
| PTMPGQQGVHSNPAM | 2116 | Q09472 | |
| QQQLQPPMGGMSPQA | 2151 | Q09472 | |
| QQQMGSPVQPNPMSP | 2266 | Q09472 | |
| MPTAQGGMPPTPQAA | 546 | Q96L91 | |
| QVPGMQMGQPVPETG | 16 | P28676 | |
| NVKGMMGPGVNPTTP | 181 | A8MVX0 | |
| PMSLGNVQLPQAPMG | 726 | Q92793 | |
| NQVSGPVMPSMPPGQ | 2006 | Q92793 | |
| GSPGQPNPMSPQQHM | 2306 | Q92793 | |
| PNPMSPQQHMLSGQP | 2311 | Q92793 | |
| QGGPGMGPPMPTVNR | 996 | Q8NFD5 | |
| NGQTMPVLPGPPVQM | 201 | P17544 | |
| MEFGPPNQQMSPSPM | 21 | P56177 | |
| QPMPPGMGTSTSHQP | 611 | Q9HBB8 | |
| GPIPSGMQGPSPINM | 476 | P33240 | |
| GMQGPSPINMGAVVP | 481 | P33240 | |
| GGPPRPNRGMPQMNT | 691 | Q14444 | |
| MPGMPSPPVLVNAAQ | 656 | Q6IQ32 | |
| MGPQPPPEANGVIMM | 76 | Q86Y37 | |
| PQPSQQPGLQPMMPN | 551 | Q9Y2K5 | |
| MPVPGNPAVPGMPNA | 641 | Q9NTZ6 | |
| GPSMNLPNQPPSAMV | 181 | Q5T481 | |
| MHPFTGVMPQTPGQP | 196 | Q5T481 | |
| RPYGPNMANMPPQVG | 866 | O14497 | |
| PEGNMSTGAPQPNLM | 1296 | O14497 | |
| APPGTNAQQNMPPQM | 1466 | O14497 | |
| TMANNLPMQPPVPSQ | 336 | P26367 | |
| QRQPMPASMPGTLPN | 171 | Q02930 | |
| PGVMNQGVAPMVGTP | 1536 | Q86U86 | |
| GAPMAQPPTPGVLMV | 116 | Q9UJ55 | |
| GTPMAQPPAPGVLMA | 226 | Q9UJ55 | |
| QPPPAAMMTQPQPSG | 261 | Q9UJ55 | |
| QNSPRMGQPGSGSMP | 511 | Q99700 | |
| MDEQSQGMQGPPVPQ | 1 | Q8TDX7 | |
| PPSGPPNMAVGNMSV | 1076 | P08151 | |
| VPKGAMGNMGSVPPQ | 1416 | P10070 | |
| MGNMGSVPPQPPPQD | 1421 | P10070 | |
| MSQASMQPALPPGVN | 116 | O75400 | |
| ANQNNPMMPRPPTLG | 901 | Q8IZL2 | |
| MNNPATVMIPPGGNV | 176 | Q14686 | |
| GQPQQGPPSQLMGMH | 611 | Q14686 | |
| MMVNPPSQNLGPSPQ | 661 | Q14686 | |
| VMPGPAQIMRGPTPN | 736 | Q14686 | |
| QMNMSPPPGNAGPVI | 146 | Q86U42 | |
| MEPSATPGAQMGVPP | 1 | O43613 | |
| AQPGPMVAPGENMTL | 1071 | Q8N6C5 | |
| ETMGVPPDSPQMTPG | 546 | Q4AC94 | |
| MGAQPPVAQVMPGAQ | 356 | O75553 | |
| DMVVSQPAGTPPGMP | 856 | O75912 | |
| CITGPAQVPMMSPNG | 56 | Q9Y2H6 | |
| AQVPMMSPNGSVPPI | 61 | Q9Y2H6 | |
| IQGPAEVPMMSPNGS | 61 | Q53EP0 | |
| EPPMVPQGRMGFPQG | 1126 | O00512 | |
| MDEKNGPPPPNMTTN | 106 | Q01543 | |
| AAQSPMGMNLPGQQP | 1151 | Q86UU0 | |
| GPPQNSMMMAPGGPD | 1196 | Q86UU0 | |
| QGSLMGPPPQQNLMV | 1456 | Q86UU0 | |
| MNPGVMSTQPVPAPS | 211 | Q8NET4 | |
| PPNSLGPAMPGINMG | 226 | Q9BWW4 | |
| GPQPMMAAAQPSQPQ | 301 | O75157 | |
| PPQQPSSMQTGMNPS | 156 | Q8N5C8 | |
| PNMSPPGMWQPGVQQ | 186 | Q86VE3 | |
| SGPPVQMYQMPPGSL | 216 | Q9Y6Y8 | |
| QMHGTEMANSPQPPP | 521 | Q9UHV7 | |
| CPLPAMPMQGGAQSP | 41 | P47972 | |
| FPNQQTPPSMMPGAV | 1051 | Q8TAQ2 | |
| YGIPPQMGSVPVMTQ | 611 | Q13492 | |
| MQPPPQTVPSGMAGP | 1 | O15027 | |
| PGVTPPNSIMGSMMP | 301 | Q8WU79 | |
| GSMMPPPVGMVAQPG | 311 | Q8WU79 | |
| APAGNQGPPPMMGMN | 411 | Q8WXF1 | |
| MNNRATIPGPPMGPG | 426 | Q8WXF1 | |
| RFPQGPPSQMGSPMG | 466 | Q8WXF1 | |
| MMPYGTGLTPQPIQN | 31 | P20226 | |
| PAPPTQNMPMGPGGM | 76 | Q15532 | |
| QMPGPNHMPMQGPGP | 126 | Q15532 | |
| PMGNYGPRPNMSMQP | 186 | Q15532 | |
| GPRPNMSMQPNQGPM | 191 | Q15532 | |
| PGSQPSPHNPNAPMM | 126 | Q9BWG4 | |
| QPMYQQMAPSGGPPQ | 736 | O14964 | |
| VPPDMMQPQQPYTGQ | 51 | Q969M3 | |
| PSDPEVPVPMGGMSQ | 406 | O15090 | |
| PMNMAQMGPPGPQGQ | 611 | Q9C0J8 | |
| QEIRGMQGPPPQGSM | 831 | Q9C0J8 | |
| MQGPPPQGSMLGPPQ | 836 | Q9C0J8 | |
| MNVRPEQPQFSPMPG | 1371 | Q04912 | |
| GAPQMQGNPTMVPLP | 556 | Q15637 | |
| AVQGPVPGMPPMTQA | 136 | P09012 | |
| TPSGMSGPPMGMNQP | 356 | Q9ULJ6 | |
| PTPAQATMAMGPQQP | 3181 | Q15911 | |
| QQPPPFGTVPPQMMF | 31 | P20592 |